ESR1 and breast cancer: As an endogenous selective ER modulator (SERM), 27HC exhibited sufficient estrogenic activity to support the proliferation of ER-positive BC cells [17, 19, 42, 43], which might contribute to the identification of drug-targets and the design of novel therapies in BC patients.